Foreword | p. xiii |
Preface | p. xv |
Acknowledgments | p. xvii |
About the Authors | p. xix |
Introduction to Pediatric Neuropsychology | p. 1 |
What Is Pediatric Neuropsychology? | p. 1 |
Neuropsychological Assessment | p. 3 |
Interpretation | p. 9 |
Why Neuropsychological Assessment? | p. 10 |
Linking Assessment to Intervention | p. 11 |
Concluding Comments | p. 12 |
Learning Disabilities: Reading Disability/Dyslexia | p. 15 |
Definition | p. 15 |
Etiology | p. 17 |
Course and Prognosis | p. 23 |
Evidence-Based Interventions | p. 25 |
Case Study: Cord-Dyslexia | p. 28 |
Concluding Comments | p. 39 |
Learning Disabilities: Dyscalculia/Math Disability | p. 41 |
Definition | p. 41 |
Etiology | p. 44 |
Course and Prognosis | p. 48 |
Evidence-Based Interventions | p. 53 |
Case Study: Carl-Dyscalculia | p. 53 |
Concluding Comments | p. 62 |
Specific Language Impairment/Dysphasia | p. 63 |
Definition | p. 63 |
Etiology | p. 66 |
Course and Prognosis | p. 72 |
Evidence-Based Interventions | p. 77 |
Case Study: Naya-Dysphasia/SLI | p. 79 |
Concluding Comments | p. 87 |
Autism Spectrum Disorders | p. 89 |
Definition | p. 89 |
Etiology | p. 91 |
Course and Prognosis | p. 100 |
Evidence-Based Interventions | p. 106 |
Case Study: John-Asperger's Disorder | p. 108 |
Concluding Comments | p. 119 |
Attention-Deficit/Hyperactivity Disorder | p. 121 |
Definition | p. 121 |
Etiology | p. 124 |
Course and Prognosis | p. 127 |
Evidence-Based Interventions | p. 129 |
Case Study: Eddie-Attention-Deficit/Hyperactivity Disorder, Combined Type | p. 137 |
Concluding Comments | p. 145 |
Tourette Syndrome | p. 147 |
Definition | p. 147 |
Etiology | p. 148 |
Course and Prognosis | p. 152 |
Evidence-Based Interventions | p. 162 |
Case Study: Moses-Tourette Syndrome | p. 167 |
Concluding Comments | p. 178 |
Traumatic Brain Injury | p. 181 |
Definition | p. 181 |
Course and Prognosis | p. 184 |
Evidence-Based Interventions | p. 193 |
Case Study: Gage-Traumatic Brain Injury | p. 198 |
Concluding Comments | p. 206 |
Childhood Cancer | p. 207 |
Definition | p. 207 |
Etiology | p. 209 |
Course and Prognosis | p. 211 |
Evidence-Based Interventions | p. 217 |
Case Study: David-Lymphocytic Leukemia | p. 220 |
Case Study: Jay-Astrocytoma | p. 228 |
Concluding Comments | p. 236 |
Epilepsy | p. 237 |
Definition | p. 237 |
Etiology | p. 239 |
Course and Prognosis | p. 240 |
Evidence-Based Interventions | p. 246 |
Case Study: Zoey-Complex Partial Seizures with Temporal Lobe Origin | p. 251 |
Case Study: Lane-Landau-Kleffner Syndrome (Epileptic Aphasia) | p. 260 |
Concluding Comments | p. 272 |
Cerebrovascular Disease: Focus on Sickle Cell Disease | p. 273 |
Definition | p. 273 |
Etiology | p. 274 |
Course and Prognosis | p. 275 |
Evidence-Based Interventions | p. 279 |
Case Study: Lania-Sickle Cell Disease without Stroke | p. 281 |
Case Study: Jed-Sickle Cell Disease with Stroke | p. 294 |
Concluding Comments | p. 305 |
Low Birth Weight | p. 307 |
Definition | p. 307 |
Etiology | p. 307 |
Course and Prognosis | p. 309 |
Evidence-Based Interventions | p. 317 |
Case Study: Emily-Extremely Low Birth Weight | p. 322 |
Concluding Comments | p. 332 |
Environmental Toxin Exposure | p. 335 |
Definition and Etiology | p. 335 |
Course and Prognosis | p. 341 |
Evidence-Based Interventions | p. 346 |
Case Study: Demetric-Lead Exposure | p. 347 |
Concluding Comments | p. 357 |
Neurotoxins, Pregnancy, and Subsequent Disorders | p. 359 |
Definition and Etiology | p. 359 |
Course and Prognosis: FASD and Illicit Drugs | p. 366 |
Case Study: Caleb-Fetal Alcohol Syndrome | p. 368 |
Course and Prognosis: Antiepileptics and FVS | p. 377 |
Case Study: Keisha-Fetal Valproate Syndrome | p. 378 |
Evidence-Based Interventions | p. 384 |
Concluding Comments | p. 385 |
Chromosomal Anomalies | p. 387 |
Autosomal Abnormalities: Down Syndrome | p. 387 |
Fragile X | p. 392 |
Williams Syndrome | p. 397 |
Angelman Syndrome | p. 403 |
Prader-Willi Syndrome | p. 407 |
Case Study: George-Angelman Syndrome | p. 413 |
Sex Chromosome Disorders | p. 417 |
Case Study: Walter-Noonan Syndrome | p. 424 |
Concluding Comments | p. 431 |
Neurocutaneous Disorders | p. 433 |
Neurofibromatosis | p. 433 |
Case Study: Gino-Neurofibromatosis Type 1 | p. 438 |
Tuberous Sclerosis Complex | p. 448 |
Case Study: Hector-Tuberous Sclerosis | p. 452 |
Sturge-Weber Syndrome | p. 463 |
Case Study: Juliana-Sturge-Weber Syndrome | p. 466 |
Concluding Comments | p. 475 |
Metabolic Disorders | p. 477 |
Type 1 Diabetes | p. 477 |
Case Study: Sam-Type 1 Diabetes | p. 484 |
Phenylketonuria | p. 494 |
Case Study: Vinnie-PKU | p. 499 |
Mucopolysaccharide Disorders | p. 512 |
Concluding Comments | p. 514 |
Looking Back, Looking Forward | p. 517 |
Assessment to Intervention Planning in Pediatric Neuropsychology | p. 517 |
Summary of Intervention Issues | p. 525 |
Conclusion and Future Directions | p. 527 |
References | p. 529 |
Author Index | p. 687 |
Subject Index | p. 709 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.